{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:35:59Z","timestamp":1764783359139},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":2746,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1093\/annonc\/mdr553","type":"journal-article","created":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T03:47:14Z","timestamp":1322192834000},"page":"1809-1812","source":"Crossref","is-referenced-by-count":43,"title":["Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe H\u00e4matologie und Onkologie OSHO-53 phase II study"],"prefix":"10.1016","volume":"23","author":[{"given":"T.","family":"Kiefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sp\u00e4th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sch\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.K.","family":"Al-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-H.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Helke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Busemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vogelgesang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Montemurro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"D\u00f6lken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr553_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","article-title":"Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315","volume":"23","author":"Nelson","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdr553_bb0015","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1200\/JCO.2003.01.135","article-title":"Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002","volume":"21","author":"Ferreri","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr553_bb0020","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1200\/JCO.1998.16.3.864","article-title":"High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series","volume":"16","author":"Blay","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr553_bb0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/annonc\/mdl458","volume":"18","author":"Montemurro","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr553_bb0030","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1200\/JCO.2003.03.108","article-title":"High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962","volume":"21","author":"Poortmans","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr553_bb0035","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","article-title":"Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10","volume":"20","author":"DeAngelis","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr553_bb0040","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdr553_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-010-0497-x","article-title":"Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?","volume":"104","author":"Omuro","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1093\/annonc\/mdr553_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/annonc\/mdn628","article-title":"High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study","volume":"20","author":"Illerhaus","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr553_bb0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1212\/01.WNL.0000137050.43114.42","article-title":"Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide","volume":"63","author":"Enting","year":"2004","journal-title":"Neurology"},{"key":"10.1093\/annonc\/mdr553_bb0060","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/WNL.54.8.1707","article-title":"PCV salvage chemotherapy for recurrent primary CNS lymphoma","volume":"54","author":"Herrlinger","year":"2000","journal-title":"Neurology"},{"key":"10.1093\/annonc\/mdr553_bb0065","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2005.01.161","article-title":"Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma","volume":"23","author":"Nguyen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr553_bb0070","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ejca.2004.03.008","article-title":"Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial","volume":"40","author":"Reni","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr553_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-007-9464-6","article-title":"Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma","volume":"86","author":"Voloschin","year":"2008","journal-title":"J Neurooncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/7\/1809\/518183\/mdr553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:10:39Z","timestamp":1624698639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341938007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S092375341938007X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr553","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}